Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 3
Submit an article Journal homepage
327
Views
31
CrossRef citations to date
0
Altmetric
Letter to the Editor

Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma

Takaaki Konuma Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Jun Ooi Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, JapanCorrespondence[email protected]
, M.D.,
Satoshi Takahashi Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Akira Tomonari Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Nobuhiro Tsukada Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Takeshi Kobayashi Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Aki Sato Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
,
Arinobu Tojo Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
&
Shigetaka Asano Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
 show all
Pages 630-632 | Received 15 Oct 2006, Accepted 18 Nov 2006, Published online: 01 Jul 2009

References

  • Farcet J P, Gaulard P, Marolleau J P, Le Couedic J P, Henni T, Gourdin M F, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 1990; 75: 2213–2219
  • Cooke C B, Krenacs L, Stetler-Stevenson M, Greiner T C, Raffeld M, Kingma D W, et al. Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gammadelta T-cell origin. Blood 1996; 88: 4265–4274
  • Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991–997
  • Belhadj K, Reyes F, Farcet J P, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261–4269
  • Jonveaux P, Daniel M T, Martel V, Maarek O, Berger R. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia 1996; 10: 1453–1455
  • Ooi J, Iseki T, Adachi D, Yamashita T, Tomonari A, Tojo A, et al. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica 2001; 86: E25
  • Weidmann E, Hinz T, Klein S, Schui D K, Harder S, Kriener S, et al. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features. Haematologica 2000; 85: 1024–1031
  • Aldinucci D, Poletto D, Zagonel V, Rupolo M, Degan M, Nanni P, et al. In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. Br J Haematol 2000; 110: 188–196
  • Przybylski G K, Wu H, Macon W R, Finan J, Leonard D G, Felgar R E, et al. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different V delta subsets of gamma/delta T lymphocytes. J Mol Diag 2000; 2: 11–19
  • Rossbach H C, Chamizo W, Dumont D P, Barbosa J L, Sutcliffe M J. Hepatosplenic gamma/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl. J Pediatr Hematol Oncol 2002; 24: 154–157
  • Gassas A, Kirby M, Weitzman S, Ngan B, Abla O, Doyle J J. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation. Am J Hematol 2004; 75: 113–114
  • Domm J A, Thompson M, Kuttesch J F, Acra S, Frangoul H. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma. J Pediatr Hematol Oncol 2005; 27: 607–610
  • Takaku T, Miyazawa K, Sashida G, Shoji N, Shimamoto T, Yamaguchi N, et al. Hepatosplenic gammadelta T-cell lymphoma with myelodysplastic syndrome. Int J Hematol 2005; 82: 143–147
  • Sakai R, Fujisawa S, Fujimaki K, Kanamori H, Ishigatsubo Y, et al. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation. Bone Marrow transplant 2006; 37: 537–538
  • Mittal S, Milner B J, Johnston P W, Culligan D J, et al. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur J Haematol 2006; 76: 531–534

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.